Mengli Yan
Impact in
-
- Liver physiology and pathology
-
- Hippo pathway signaling and YAP/TAZ
Papers in
-
- Extracellular vesicles in disease 2
-
- Ferroptosis and cancer prognosis 3
- Co-authors
- Bi‐Sen Ding (3 shared papers)Meng Yu (2 shared papers)Xiantao Ma (1 shared paper)Qing Xu (1 shared paper)Yafeng Ren (2 shared papers)Ke Liu (2 shared papers)Ran Yan (1 shared paper)Jing Yu (1 shared paper)
- Journals
- International Journal of Molecular Sciences (2 papers)BMJ Open Diabetes Research & Care (1 paper)Aging (1 paper)Journal of Hepatology (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited StatesMexico
In The Last Decade
Mengli Yan
11 papers receiving 221 citations
Peers
Comparison fields: 5 of 62
- Hepatology 32
- Cell Biology 41
- Ophthalmology 21
- Pulmonary and Respiratory Medicine 57
- Cancer Research 21
Countries citing papers authored by Mengli Yan
This map shows the geographic impact of Mengli Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengli Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengli Yan more than expected).
Fields of papers citing papers by Mengli Yan
This network shows the impact of papers produced by Mengli Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengli Yan. The network helps show where Mengli Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengli Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 71 | |
| 2 | 2021 | 65 | |
| 3 | 2019 | 30 | |
| 4 | 2021 | 20 | |
| 5 | 2023 | 12 | |
| 6 | 2024 | 10 | |
| 7 | 2024 | 6 | |
| 8 | 2022 | 4 | |
| 9 | 2019 | 3 | |
| 10 | 2025 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2025 | 0 |
About Mengli Yan
Mengli Yan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Endocrinology, Diabetes and Metabolism and Cell Biology, having authored 13 papers that have together received 223 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), Liver physiology and pathology (2 papers), Gas Sensing Nanomaterials and Sensors (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Extracellular vesicles in disease (2 papers), Advanced Chemical Sensor Technologies (1 paper), Electrochemical sensors and biosensors (1 paper) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). The work is most often cited by research in Hepatology (32 citations), Cell Biology (41 citations), Ophthalmology (21 citations), Pulmonary and Respiratory Medicine (57 citations) and Cancer Research (21 citations). Mengli Yan has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Bi‐Sen Ding, Meng Yu, Xiantao Ma, Qing Xu, Yafeng Ren, Ke Liu, Ran Yan, Jing Yu, Jian Liu and Jie Qing. Their work appears in journals such as International Journal of Molecular Sciences, BMJ Open Diabetes Research & Care, Aging, Journal of Hepatology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.